Home › NDC Lookup › RxCUI directory › RxCUI 751616

Nebivolol 10 MG Oral Tablet [Bystolic] — RxCUI 751616

Name: Nebivolol 10 MG Oral Tablet [Bystolic] (RxCUI 751616)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 751616 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI751616

Official nameNebivolol 10 MG Oral Tablet [Bystolic]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asBystolic 10 MG Oral Tablet; Bystolic (as nebivolol HCl) 10 MG Oral Tablet

FDA products mapped4

Package NDCs mapped13

Reported Medicaid activity (SDUD)1,480 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nebivolol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Nebivolol is used to treat high blood pressure — that's its approved use. By bringing your blood pressure down, it helps lower your risk of serious problems like stroke and heart a...
Please don't stop it suddenly without talking to your doctor first. If you have any underlying heart disease, stopping abruptly can trigger chest pain, a heart attack, or dangerous...
Can I stop taking nebivolol if I feel fine or don't like the side effects?
No — nebivolol can be taken with or without food. It doesn't change how the drug is absorbed or how well it works. The most important thing is to take it at roughly the same time e...

📖 Read our full Nebivolol guide →

🕸️ Concept Web — How Nebivolol 10 MG Oral Tablet [Bystolic] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Nebivolol 10 MG Oral Tablet [Bystolic] RxCUI 751616 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Nebivolol 31555 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Bystolic 751613 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Nebivolol Oral Tablet 393308 SCDF
- Nebivolol Oral Product 1158401 SCDG
- Nebivolol Pill 1158402 SCDG
- Nebivolol Oral Tablet [Bystolic] 751615 SBDF
- Bystolic Oral Product 1169416 SBDG
- Bystolic Pill 1169417 SBDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Nebivolol 10 MG Oral Tablet 751612 SCD
- Nebivolol 10 MG 751611 SCDC
- Nebivolol 10 MG [Bystolic] 751614 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Nebivolol 10 MG Oral Tablet SCD · 751612
Nebivolol 10 MG SCDC · 751611
Nebivolol Oral Tablet SCDF · 393308
Nebivolol Oral Product SCDG · 1158401
Nebivolol Pill SCDG · 1158402

Brand-Name Concepts

Nebivolol 10 MG [Bystolic] SBDC · 751614
Nebivolol Oral Tablet [Bystolic] SBDF · 751615
Bystolic Oral Product SBDG · 1169416
Bystolic Pill SBDG · 1169417
Bystolic BN · 751613

📦 FDA Products & Package NDCs

4 products · 13 package NDCs

13 package NDCs map to RxCUI 751616 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00456-1402-01	100 TABLET in 1 BOTTLE (0456-1402-01)	Bystolic	Allergan, Inc.	2008-01-22
00456-1402-30	30 TABLET in 1 BOTTLE (0456-1402-30)	Bystolic	Allergan, Inc.	2008-01-22
00456-1402-90	90 TABLET in 1 BOTTLE (0456-1402-90)	Bystolic	Allergan, Inc.	2008-01-22
00456-1405-01	100 TABLET in 1 BOTTLE (0456-1405-01)	Bystolic	Allergan, Inc.	2008-01-22
00456-1405-30	30 TABLET in 1 BOTTLE (0456-1405-30)	Bystolic	Allergan, Inc.	2008-01-22
00456-1405-90	90 TABLET in 1 BOTTLE (0456-1405-90)	Bystolic	Allergan, Inc.	2008-01-22
00456-1410-01	100 TABLET in 1 BOTTLE (0456-1410-01)	Bystolic	Allergan, Inc.	2008-01-22
00456-1410-30	30 TABLET in 1 BOTTLE (0456-1410-30)	Bystolic	Allergan, Inc.	2008-01-22
00456-1410-63	100 TABLET in 1 BOX, UNIT-DOSE (0456-1410-63)	Bystolic	Allergan, Inc.	2008-01-22
00456-1410-90	90 TABLET in 1 BOTTLE (0456-1410-90)	Bystolic	Allergan, Inc.	2008-01-22
00456-1420-01	100 TABLET in 1 BOTTLE (0456-1420-01)	Bystolic	Allergan, Inc.	2008-01-22
00456-1420-63	100 TABLET in 1 BOX, UNIT-DOSE (0456-1420-63)	Bystolic	Allergan, Inc.	2008-01-22
00456-1420-90	90 TABLET in 1 BOTTLE (0456-1420-90)	Bystolic	Allergan, Inc.	2008-01-22

Observed labelers: Allergan, Inc. (13) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.